Port Matthias, Hérodin Francis, Valente Marco, Drouet Michel, Lamkowski Andreas, Majewski Matthäus, Abend Michael
Bundeswehr Institute of Radiobiology affiliated to the University of Ulm, Neuherbergstr. 11, 80937, Munich, Germany.
Institut de Recherche Biomedicale des Armees, Bretigny-sur-Orge, France.
Ann Hematol. 2017 May;96(5):859-870. doi: 10.1007/s00277-017-2952-7. Epub 2017 Feb 24.
Based on gene expression changes measured in the peripheral blood within the first 2 days after irradiation, we predicted a pancytopenia in a baboon model. Eighteen baboons were irradiated with 2.5 or 5 Gy. According to changes in blood cell counts, the surviving baboons (n = 17) exhibited a hematological acute radiation syndrome (HARS) either with or without a pancytopenia. We used a two stage study design where stage I was a whole genome screen (microarrays) for mRNA combined with a qRT-PCR platform for simultaneous detection of 667 miRNAs using a part of the samples. Candidate mRNAs and miRNAs differentially upregulated or downregulated (>2-fold, p < 0.05) during the first 2 days after irradiation were chosen for validation in stage II using the remaining samples and using throughout more sensitive qRT-PCR. We detected about twice as many upregulated (mean 2128) than downregulated genes (mean 789) in baboons developing an HARS either with or without a pancytopenia. From 51 candidate mRNAs altogether, 11 mRNAs were validated using qRT-PCR. These mRNAs showed only significant differences between HARS groups and H0, but not between HARS groups with and without pancytopenia. Six miRNA species (e.g., miR-574-3p, p = 0.009, ROC = 0.94) revealed significant gene expression differences between HARS groups with and without pancytopenia and are known to sensitize irradiated cells. Hence, in particular, the newly identified miRNA species for prediction of pancytopenia will support the medical management decision making.
基于照射后前两天在外周血中测量到的基因表达变化,我们在狒狒模型中预测了全血细胞减少症。18只狒狒接受了2.5或5 Gy的照射。根据血细胞计数的变化,存活的狒狒(n = 17)表现出伴有或不伴有全血细胞减少症的血液学急性放射综合征(HARS)。我们采用两阶段研究设计,其中第一阶段是对mRNA进行全基因组筛选(微阵列),并结合qRT-PCR平台,使用部分样本同时检测667种miRNA。在照射后前两天差异上调或下调(>2倍,p < 0.05)的候选mRNA和miRNA被选择用于第二阶段的验证,使用剩余样本并全程使用更灵敏的qRT-PCR。在发生伴有或不伴有全血细胞减少症的HARS的狒狒中,我们检测到上调基因(平均2128个)的数量大约是下调基因(平均789个)的两倍。在总共51个候选mRNA中,有11个mRNA通过qRT-PCR得到验证。这些mRNA仅在HARS组与H0组之间显示出显著差异,而在伴有和不伴有全血细胞减少症的HARS组之间没有差异。六种miRNA(例如,miR-574-3p,p = 0.009,ROC = 0.94)在伴有和不伴有全血细胞减少症的HARS组之间显示出显著的基因表达差异,并且已知它们能使受照射细胞敏感。因此,特别是新鉴定出的用于预测全血细胞减少症的miRNA将有助于医疗管理决策。